Ontogenetic development of the response to anandamide and Δ9-tetrahydrocannabinol in mice

Developmental Brain Research

Volumn 95, Issue 1, 1996, Pages 131-134

  Fride, Ester ^a   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anandamide; Antiemetic; Behavior; Cannabinoids; Development; Ontogeny; Tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; TETRAHYDROCANNABINOL;

ADOLESCENT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0030595002     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-3806(96)00087-9     Document Type: Article

References (20)

1. [1] Abrahamov, A., Abrahamov, A. and Mechoulam, R., An efficient new cannabinoid antiemetic in pediatric oncology, Life Sci., 56 (1995) 2097-2102.
2. [2] Ankier, S.I., New hot plate tests to quantify antinociception and narcotic antagonist activities, Eur. J. Pharmacol., 27 (1974) 1-4.
3. [3] Barg, J., Fride, E., Hanuš, L., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M., Mechoulam, R. and Vogel, Z., Cannabimimetic behavioral effects and adenylate cyclase inhibition by two new endogenous anandamides, Eur. J. Pharmacol., 287 (1995) 145-152.
4. [4] Belue, R.C., Howlett, A.C., Westlake, T.M. and Hutchings, D.E., The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats, Neurotoxicol. Teratol., 17 (1994) 25-30.
5. [5] Devane, W.A., Hanuš, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258 (1992) 1946-1949.
6. [6] Di Marzo, V., Fontana, A., Cadas, H., Schinelli, G.C., Schwartz, J.-C. and Piomelli, D., Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature, 372 (1994) 686-690.
7. [7] Eddy, N.B., Fuhrmeister Touchberry, C. and Lieberman, J.E., Synthetic analgesics. I. Methadon isomers and derivatives J. Pharmacol., 98 (1953) 121-137.
8. [8] Facci, L., Dal Toso, S., Romanello, A., Buriani, A., Skaper, S.D. and Leon, A., Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide, Proc. Natl. Acad. Sci. USA, 92 (1995) 3376-3380.
9. [9] Feigenbaum, J.J., Richmond, S.A., Weissman, Y. and Mechoulam, R., Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid, Eur. J. Pharmacol., 169 (1989) 159-165.
10. [10] Felder, C.C., Veluz, J.S., Williams, H.L., Briley, E.M. and Matsuda, L.A., Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones, Mol. Pharmacol., 42 (1992) 838-845.
11. 9-tetrahydrocannabinol, J. Pharmacol. Exp. Ther., 272 (1995) 699-707.
12. [12] Fride, E. and Mechoulam, R., Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent, Eur. J. Pharmacol., 231 (1993) 313-314.
13. [13] Fride, E. and Mechoulam, R., The anandamide-cannabinoid system in the mouse: ontogeny and prenatal manipulation, Psychoneuroendocrinology, (1995) in press.
14. [14] Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de-Costa, B.R. and Rice, K.C., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci., 11 (1991) 563-583.
15. [15] Mackie, K., Devane, W.A. and Hille, B., Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells, Mol. Pharmacol., 44 (1993) 498-503.
16. [16] Martin, B.R., Cellular effects of cannabinoids, Pharmacol. Rev., 38 (1986) 45-74.
17. [17] McLaughlin, C.R. and Abood, M.E., Developmental expression of cannabinoid receptor mRNA, Dev. Brain Res., 76 (1993) 75-78.
18. [18] Mechoulam, R. and Fride, E., The unpaved road to the endogenous cannabinoid ligand anandamide. In: R.G. Pertwee (Ed.), Cannabinoid Receptors, Academic Press, New York, 1995, pp. 233-258.
19. [19] Rodriguez de Fonseca, F., Ramos, J.A., Bonnin, A. and Fernandez-Ruiz, J.J., Presence of cannabinoid binding sites in the brain from early postnatal ages, Neuroreport, 4 (1993) 135-138.
20. [20] Smith, P.B., Compton, D.R., Welch, S.P., Razdan, R.K., Mechoulam R. and Martin, B.R., The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice, J. Pharmacol. Exp. Ther., 270 (1994) 219-227.